Association of HER2/CEP17 ratio with pCR after HER2-directed neoadjuvant treatments in the phase III NeoALTTO trial

CF Singer; F Konig; S Kacerovsky-Strobl; S Danzinger; C Brunner; Christoph Suppan; C Deutschmann; Marija Balic; R Greil; D Egle; E De Azambuja; S Di Cosimo; M Gnant

Association of HER2/CEP17 ratio with pCR after HER2-directed neoadjuvant treatments in the phase III NeoALTTO trial

CF Singer
, F Konig
, S Kacerovsky-Strobl
, S Danzinger
, C Brunner
, Christoph Suppan
, C Deutschmann
, Marija Balic
, R Greil
, D Egle
, E De Azambuja
, S Di Cosimo
, M Gnant

Publikation: Beitrag in Fachzeitschrift › Konferenzabstract

1 Quellenangabe (Web of Science)

Originalsprache	Englisch
Seitenumfang	1
Fachzeitschrift	Journal of Clinical Oncology
Jahrgang	41
Ausgabenummer	16
Publikationsstatus	Veröffentlicht - 1 Juni 2023
Veranstaltung	59th Annual Meeting of the American Society of Clinical Oncology - Chicago, USA/Vereinigte Staaten Dauer: 2 Juni 2023 → 6 Juni 2023

Wissenschaftszweige

302 Klinische Medizin

Andere Dateien und Links

Web of Science

Association of HER2/CEP17 ratio with pCR after HER2-directed neoadjuvant treatments in the phase III NeoALTTO trial
Singer, C. (Autor*in), Konig, F. (Autor*in), Kacerovsky-Strobl, S. (Autor*in), Danzinger, S. (Autor*in), Brunner, C. (Autor*in), Suppan, C. (Autor*in), Deutschmann, C. (Autor*in), Balic, M. (Autor*in), Greil, R. (Autor*in), Egle, D. (Autor*in), De Azambuja, E. (Autor*in), Di Cosimo, S. (Autor*in) & Gnant, M. (Autor*in)
2023
Aktivität: Vortrag oder Poster › Poster

Dieses zitieren

@article{748e9a9264974516be158d6dc9ea0886,

title = "Association of HER2/CEP17 ratio with pCR after HER2-directed neoadjuvant treatments in the phase III NeoALTTO trial",

author = "CF Singer and F Konig and S Kacerovsky-Strobl and S Danzinger and C Brunner and Christoph Suppan and C Deutschmann and Marija Balic and R Greil and D Egle and \{De Azambuja\}, E and \{Di Cosimo\}, S and M Gnant",

year = "2023",

month = jun,

day = "1",

language = "English",

volume = "41",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

publisher = "Lippincott Williams and Wilkins",

number = "16",

note = "59th Annual Meeting of the American Society of Clinical Oncology, ASCO 59 ; Conference date: 02-06-2023 Through 06-06-2023",

}

TY - JOUR

T1 - Association of HER2/CEP17 ratio with pCR after HER2-directed neoadjuvant treatments in the phase III NeoALTTO trial

AU - Singer, CF

AU - Konig, F

AU - Kacerovsky-Strobl, S

AU - Danzinger, S

AU - Brunner, C

AU - Suppan, Christoph

AU - Deutschmann, C

AU - Balic, Marija

AU - Greil, R

AU - Egle, D

AU - De Azambuja, E

AU - Di Cosimo, S

AU - Gnant, M

PY - 2023/6/1

Y1 - 2023/6/1

UR - https://www.webofscience.com/wos/woscc/full-record/WOS:001053772000101

M3 - Conference abstract

SN - 0732-183X

VL - 41

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

IS - 16

T2 - 59th Annual Meeting of the American Society of Clinical Oncology

Y2 - 2 June 2023 through 6 June 2023

ER -

Association of HER2/CEP17 ratio with pCR after HER2-directed neoadjuvant treatments in the phase III NeoALTTO trial

Wissenschaftszweige

Andere Dateien und Links

Aktivitäten

Association of HER2/CEP17 ratio with pCR after HER2-directed neoadjuvant treatments in the phase III NeoALTTO trial

Dieses zitieren